JR
Jason Ryan (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in GeneDx Holdings Corp. (WGS). The largest single filing was $5.0M of WGS (39,222 sh across 7 lots, as filed), executed Aug 27 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.0M
shares × price, as filed
Last traded
Aug 27 2025
Filed Aug 27 2025
Median ADV $82.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
WGSRecent filings
WGSSALE
GeneDx Holdings Corp.
View filing →
$5.0M39,222 sh across 7 lots
Exec Aug 27 2025
Filed Aug 27 2025 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. View filing → $3.3M
46,226 sh across 5 lots
Exec Nov 19 2024
Filed Nov 21 2024 · 5:30 PM ET